Results 71 to 80 of about 59,772 (269)

Drug-Induced Bullous Haemorrhagic Dermatosis: Insights from a Case Series

open access: yesJournal of Medical Sciences and Health
Bullous haemorrhagic dermatosis (BHD), a distinctive non-immune cutaneous eruption, manifests as the formation of haemorrhagic bullae on the skin.
Nikhil Era   +5 more
doaj   +1 more source

Investigation of antibacterial and anticancer activities of biosynthesized metal‐doped and undoped zinc oxide nanoparticles

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
Abstract Over the past 10 years, nanotechnology has emerged as a very promising technique for a wide range of biomedical applications. Green synthesized metal and metal oxide nanoparticles (NPs) are cheap, easy to produce in large quantities, and safe for the environment.
Kaan Şendal   +6 more
wiley   +1 more source

Acute cardiovascular effects associated with the use of prescription medications: A Danish nationwide screening study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim This study aims to conduct a hypothesis‐generating screening for acute cardiovascular effects of prescription medications. Methods This Danish nationwide screening study was conducted among incident cases of cardiovascular diseases, including myocardial infarction (MI), ischemic stroke (IS), heart failure (HF), venous thromboembolism (VTE),
Saad Hanif Abbasi   +4 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

A review of phytotherapy of Acne vulgaris [PDF]

open access: yesMakedonsko Farmacevtski Bilten, 2009
Acne vulgaris (acne) is a cutaneous pleomorphic disorder of the pilosebaceous unit involving abnormalities in sebum production and is characterized by both inflammatory (papules, pustules and nodules) and non-inflammatory (comedones, open and closed ...
Marija Glavas Dodov, Svetlana Kulevanova
doaj  

Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Thiopurines are a class of immunosuppressant and antineoplastic agents. They are widely used in the treatment of inflammatory bowel disease, haematological malignancies and autoimmune diseases, but can cause significant toxicity. Inherited gene mutations are now recognized as independent risk factors for severe adverse drug reactions to thiopurines ...
Annie Siyu Wu   +3 more
wiley   +1 more source

Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects

open access: yesFrontiers in Immunology, 2017
The number of biologicals for the therapy of immunologically mediated diseases is constantly growing. In contrast to other agents that were previously introduced in rheumatologic or dermatologic diseases and only later adopted for the treatment of ...
Sebastian Zundler   +4 more
doaj   +1 more source

Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application

open access: yesBMEMat, EarlyView.
The graphical abstract illustrates the diverse nanostructures employed in transdermal drug delivery systems, highlighting their unique mechanisms to penetrate the intricate layers of skin. It provides a detailed representation of the skin's complex anatomy, emphasizing the challenges posed by its barrier properties.
Syed Waqas Ali Shah   +9 more
wiley   +1 more source

A review of clinical photoacoustic imaging: Current and future trends

open access: yesPhotoacoustics, 2019
Photoacoustic imaging (or optoacoustic imaging) is an upcoming biomedical imaging modality availing the benefits of optical resolution and acoustic depth of penetration. With its capacity to offer structural, functional, molecular and kinetic information
Amalina Binte Ebrahim Attia   +6 more
doaj  

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib

open access: yesJournal of Hematology & Oncology, 2010
Imatinib, a tyrosine kinase inhibitor (TKI) of BCR-ABL, was the standard first-line therapy for chronic myeloid leukemia (CML) for almost 10 years. Dasatinib and nilotinib, two newer drugs with higher potency than imatinib against BCR-ABL and activity ...
Rafiyath Shamudheen   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy